Monoox (Ofloxacin)

Ofloxacin, the active ingredient in Monoox, is a fluoroquinolone presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye such as conjunctivitis, keratitis and corneal ulcers in patients requiring prescription therapy.

GNH USA supplies Monoox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin is a fluoroquinolone antibacterial used for ocular infections affecting the conjunctiva and cornea.

- Bacterial conjunctivitis: reduces bacterial load and resolves redness and discharge. - Keratitis: eradicates causative bacteria, promoting corneal healing. - Corneal ulcer: prevents progression of infection and supports tissue repair.

Ophthalmic administration of Ofloxacin may be associated with local and systemic adverse reactions.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Redness: transient conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance. - Mild headache: occasional frontal discomfort.

Serious or Rare Side Effects: - Allergic reaction: swelling, itching, or rash around the eye. - Severe ocular inflammation: marked pain, swelling, or ulceration. - Vision loss: sudden decrease in visual acuity. - Stevens‑Johnson syndrome: rare mucocutaneous eruption. - Systemic hypersensitivity: anaphylaxis in extremely rare cases.

When prescribing Ofloxacin eye drops, clinicians should consider several safety measures.

- Allergy assessment: confirm no known hypersensitivity to fluoroquinolones. - Prescription use only: administer exactly as directed by a qualified professional. - Infection monitoring: observe for worsening signs or lack of improvement. - Contact lens avoidance: remove lenses during treatment to prevent contamination. - Storage at room temperature: keep in original container, protect from light and moisture.

Ofloxacin ophthalmic solution can interact with systemic and topical agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity. - Cimetidine or antacids containing aluminum/magnesium: may reduce systemic absorption if used orally.

Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: may mask signs of infection. - NSAID eye preparations: monitor for additive irritation. - Warfarin: observe coagulation parameters due to potential enhanced anticoagulant effect.